| Lindsay Adair Presteng, FNP-BC | |
|
816 W Midway Dr, Grafton, ND 58237-7501 | |
| (701) 352-4581 | |
| Not Available |
| Full Name | Lindsay Adair Presteng |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 816 W Midway Dr, Grafton, North Dakota |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134815574 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | R39925 (North Dakota) | Primary |
| Entity Name | Life Skills And Transition Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558427708 PECOS PAC ID: 7113986159 Enrollment ID: O20041006000563 |
News Archive
Florida-based biotechnology company Oragenics, Inc., and RICCI PHARMA, a recognized health products company with offices in Rome and Slovakia, have entered into a distribution agreement that the parties anticipate will provide Oragenics' proprietary oral care probiotic products, EvoraPlus® and EvoraKidsTM, to RICCI PHARMA. RICCI PHARMA will have exclusive distribution rights through Duc in Altum, a foundation whose humanitarian projects are inspired by the social teachings of the late Pope John Paul II.
Overactive epidermal growth factor receptor (EGFR) signaling has been linked to the development of cancer. Several drug therapies have been developed to treat these EGFR-associated cancers; however, many patients have developed resistance to these drugs and are therefore no longer responsive to drug treatment.
Studies performed by a Sanford Research scientist using an innovative stem-cell model for a fatal developmental disorder is the focus of a recent study published in Nature Medicine. Kevin Francis, Ph.D. uncovered unique cellular defects associated with Smith-Lemli-Opitz syndrome (SLOS) by modeling this disease using induced pluripotent stem cells.
Vycor Medical, Inc., a medical device company that designs, develops and markets next generation neurosurgery retraction devices, today announced its ViewSite Brain Access System (VBAS) medical retraction device continues to gain ground. This "BioTech Breakthrough" - with the potential to impact several hundreds of thousands of patients and throngs of surgeons and medical facilities worldwide - is among a pioneering new breed of cost-reducing surgical devices designed to enhance performance, quality of life and surgical results.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lindsay Adair Presteng, FNP-BC 1611 Lessard Ave, Grafton, ND 58237-2704 Ph: (701) 330-1114 | Lindsay Adair Presteng, FNP-BC 816 W Midway Dr, Grafton, ND 58237-7501 Ph: (701) 352-4581 |
News Archive
Florida-based biotechnology company Oragenics, Inc., and RICCI PHARMA, a recognized health products company with offices in Rome and Slovakia, have entered into a distribution agreement that the parties anticipate will provide Oragenics' proprietary oral care probiotic products, EvoraPlus® and EvoraKidsTM, to RICCI PHARMA. RICCI PHARMA will have exclusive distribution rights through Duc in Altum, a foundation whose humanitarian projects are inspired by the social teachings of the late Pope John Paul II.
Overactive epidermal growth factor receptor (EGFR) signaling has been linked to the development of cancer. Several drug therapies have been developed to treat these EGFR-associated cancers; however, many patients have developed resistance to these drugs and are therefore no longer responsive to drug treatment.
Studies performed by a Sanford Research scientist using an innovative stem-cell model for a fatal developmental disorder is the focus of a recent study published in Nature Medicine. Kevin Francis, Ph.D. uncovered unique cellular defects associated with Smith-Lemli-Opitz syndrome (SLOS) by modeling this disease using induced pluripotent stem cells.
Vycor Medical, Inc., a medical device company that designs, develops and markets next generation neurosurgery retraction devices, today announced its ViewSite Brain Access System (VBAS) medical retraction device continues to gain ground. This "BioTech Breakthrough" - with the potential to impact several hundreds of thousands of patients and throngs of surgeons and medical facilities worldwide - is among a pioneering new breed of cost-reducing surgical devices designed to enhance performance, quality of life and surgical results.
› Verified 4 days ago
Marie K Anderson, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1113 W 11th St, Grafton, ND 58237 Phone: 701-352-4048 Fax: 701-922-1308 | |
Mrs. Jaime Rae Mattson, FNP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 701 W 6th St, Grafton, ND 58237 Phone: 701-352-4048 Fax: 701-352-0268 | |
Lyndsey Rae Leehan, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 164 W 13th St, Grafton, ND 58237 Phone: 701-352-1620 | |
Kathleen R Schweitzer, FNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 701 W 6th St, Grafton, ND 58237 Phone: 701-352-4565 | |
Michele Schoenborn, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 164 W 13th St, Grafton, ND 58237 Phone: 701-352-1620 | |
Mrs. Emily A Balsdon, FNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 164 W 13th St, Grafton, ND 58237 Phone: 701-352-1620 |